These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 10350383

  • 1. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: results of a randomized, double-blind study.
    Shah PM, Maesen FP, Dolmann A, Vetter N, Fiss E, Wesch R.
    J Antimicrob Chemother; 1999 Apr; 43(4):529-39. PubMed ID: 10350383
    [Abstract] [Full Text] [Related]

  • 2. Clinical effectiveness of levofloxacin in patients with acute purulent exacerbations of chronic bronchitis: the relationship with in-vitro activity.
    Davies BI, Maesen FP.
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():83-90. PubMed ID: 10404344
    [Abstract] [Full Text] [Related]

  • 3. A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia.
    File TM, Segreti J, Dunbar L, Player R, Kohler R, Williams RR, Kojak C, Rubin A.
    Antimicrob Agents Chemother; 1997 Sep; 41(9):1965-72. PubMed ID: 9303395
    [Abstract] [Full Text] [Related]

  • 4. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis. The Bronchitis Study Group.
    Chodosh S, McCarty J, Farkas S, Drehobl M, Tosiello R, Shan M, Aneiro L, Kowalsky S.
    Clin Infect Dis; 1998 Oct; 27(4):722-9. PubMed ID: 9798024
    [Abstract] [Full Text] [Related]

  • 5. Open-label, randomized comparison of the efficacy and tolerability of clarithromycin, levofloxacin, and cefuroxime axetil in the treatment of adults with acute bacterial exacerbations of chronic bronchitis.
    Weiss LR.
    Clin Ther; 2002 Sep; 24(9):1414-25. PubMed ID: 12380633
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness of short-course therapy (5 days) with cefuroxime axetil in treatment of secondary bacterial infections of acute bronchitis.
    Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, Giguere G, Collins JJ.
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2528-34. PubMed ID: 8585739
    [Abstract] [Full Text] [Related]

  • 7. Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime.
    Zuck P, Petitpretz P, Geslin P, Rio Y, Leblanc F.
    Int J Clin Pract; 1999 Sep; 53(6):437-43. PubMed ID: 10622071
    [Abstract] [Full Text] [Related]

  • 8. Ciprofloxacin versus cefuroxime axetil in the treatment of acute bacterial sinusitis. Sinusitis Infection Study Group.
    Johnson PA, Rodriguez HP, Wazen JJ, Huck W, Shan M, Tosiello R, Heyd A, Echols RM.
    J Otolaryngol; 1999 Feb; 28(1):3-12. PubMed ID: 10077777
    [Abstract] [Full Text] [Related]

  • 9. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with secondary bacterial infections of acute bronchitis.
    Henry D, Ruoff GE, Rhudy J, Puopolo A, Drehobl M, Schoenberger J, Giguere G, Collins JJ.
    Clin Ther; 1995 Feb; 17(5):861-74. PubMed ID: 8595638
    [Abstract] [Full Text] [Related]

  • 10. A comparison of the safety and efficacy of moxifloxacin (BAY 12-8039) and cefuroxime axetil in the treatment of acute bacterial sinusitis in adults. The Sinusitis Study Group.
    Siegert R, Gehanno P, Nikolaidis P, Bagger-Sjöbäck D, Ibanez JM, Hampel B, Sommerauer B.
    Respir Med; 2000 Apr; 94(4):337-44. PubMed ID: 10845431
    [Abstract] [Full Text] [Related]

  • 11. Cefuroxime axetil: an updated review of its use in the management of bacterial infections.
    Scott LJ, Ormrod D, Goa KL.
    Drugs; 2001 Apr; 61(10):1455-500. PubMed ID: 11558834
    [Abstract] [Full Text] [Related]

  • 12. Ciprofloxacin versus cefuroxime axetil in the treatment of adult patients with acute bacterial sinusitis.
    Klein GL, Whalen E, Echols RM, Heyd A.
    J Otolaryngol; 1998 Feb; 27(1):10-6. PubMed ID: 9511113
    [Abstract] [Full Text] [Related]

  • 13. Clinical and bacteriological efficacy in treatment of acute exacerbations of chronic bronchitis with cefditoren-pivoxil versus cefuroxime-axetil.
    Alvarez-Sala JL, Kardos P, Martínez-Beltrán J, Coronel P, Aguilar L.
    Antimicrob Agents Chemother; 2006 May; 50(5):1762-7. PubMed ID: 16641447
    [Abstract] [Full Text] [Related]

  • 14. Sequential therapy with cefuroxime followed by cefuroxime axetil in acute exacerbations of chronic bronchitis.
    Vogel F, Droszcz W, Vondra V, Reisenberg K, Marr C, Staley H.
    J Antimicrob Chemother; 1997 Dec; 40(6):863-71. PubMed ID: 9462439
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of acute exacerbations of chronic bronchitis. Multicenter, randomized comparative study of cefuroxime axetil versus ofloxacin].
    Kleckow M.
    Fortschr Med; 1991 Jul 30; 109(22):450-4. PubMed ID: 1937326
    [Abstract] [Full Text] [Related]

  • 16. An economic evaluation of levofloxacin versus cefuroxime axetil in the outpatient treatment of adults with community-acquired pneumonia.
    Rittenhouse BE, Stinnett AA, Dulisse B, Henke CJ, Potter L, Parasuraman B, Martens LL, Williams RR, Kojak C.
    Am J Manag Care; 2000 Mar 30; 6(3):381-9. PubMed ID: 10977438
    [Abstract] [Full Text] [Related]

  • 17. A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis.
    Sethi S, Fogarty C, Fulambarker A.
    Respir Med; 2004 Aug 30; 98(8):697-707. PubMed ID: 15303633
    [Abstract] [Full Text] [Related]

  • 18. Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults.
    Siegert R, Berg O, Gehanno P, Leiberman A, Martinkenas JL, Nikolaidis P, Arvis P, Alefelder M, Reimnitz P.
    Eur Arch Otorhinolaryngol; 2003 Apr 30; 260(4):186-94. PubMed ID: 12709801
    [Abstract] [Full Text] [Related]

  • 19. Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. Sinusitis Study Group.
    Gehanno P, Berche P.
    J Antimicrob Chemother; 1996 May 30; 37 Suppl A():105-14. PubMed ID: 8737130
    [Abstract] [Full Text] [Related]

  • 20. Clinical Comparison of Cefuroxime Axetil with Cefixime in the Treatment of Acute Bronchitis.
    Arthur M, McAdoo M, Guerra J, Maloney R, McCluskey D, Giguere G, Gomez G, Collins JJ.
    Am J Ther; 1996 Sep 30; 3(9):622-629. PubMed ID: 11862302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.